Last Price | 540.75 | Max Price | 620.25 |
Min Price | 469.03 | 1 Year return | -1.81 |
Sector | Industry | Subsector | Support Services |
Annual report 2017 |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 25,542 | 665,529 | 3.84 % |
2020 | 32,218 | 640,773 | 5.03 % |
2021 | 39,211 | 697,909 | 5.62 % |
2022 | 44,915 | 798,307 | 5.63 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
Thermo Fisher bid to acquire PPD comes under regulatory scrutiny in U.K.
Thermo Fisher opens biologics manufacturing site in Switzerland
Thermo Fisher to spend $17 billion on PPD acquisition
Analysts expect over 2020 rising revenue Thermo Fisher Scientific
Analysts expect over 2020 rising revenue Thermo Fisher Scientific
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the last 12 months, that were profitable period for the investors in Thermo Fisher Scientific, the stock gained around 4 percent. Over the past 5 years the stock rose a massive 217,94 percent. Thermo Fisher Scientific's revenues between 2011 and 2015 were very volatile through the time and moved between 12,51 billion dollars and 16,97 billion dollars. Thermo Fisher Scientific's net results between 2011 and 2015 were quite unstable and moved between 1,02 billion dollars and 1,98 billion dollars.
Thermo Fisher Scientific mainly operates in the health care eq. & services sector. The global health care companies gained around 102 percent over the period 2006-2016. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.
The American company paid out dividends in the past 5 years. Over the past 5 years Thermo Fisher Scientific's dividend yield was at around 2,47 percent per year. Over the past 5 years Thermo Fisher Scientific raised her dividends share each year. Based on the yearly higher dividend payments Thermo Fisher Scientific is a kind of dividend aristocrat.
At the end of 2015 the American company's balance sheet was worth 40,89 billion dollars. 19,54 billion dollars (47,78 percent of the total balance sheet) was financed by debt. At the end of 2016 the American company was traded with a price/earnings-ratio of around 24. So investors paid 24 times the company's 2015's EPS. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the health care company's market capitalization (the number of shares times the market price) equaled around 55,73 billion dollars. At the end of 2015 the American company had around 399,63 million stocks listed on the stock exchange(s).
All the company's financial reports are available here. More information about Thermo Fisher Scientific can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
16,965
|
18,274
|
20,918
|
24,358
|
25,542
|
32,218
|
Costs |
14,990
|
16,252
|
18,693
|
21,420
|
21,846
|
25,843
|
Profit |
1,975
|
2,022
|
2,225
|
2,938
|
3,696
|
6,375
|
Margin of profit |
11.64
|
11.06
|
10.64
|
12.06
|
14.47
|
19.79
|
ROI |
9.25
|
9.39
|
8.76
|
10.65
|
12.45
|
18.47
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
21,350
|
21,539
|
25,413
|
27,586
|
29,675
|
34,507
|
Debt |
19,484
|
24,368
|
31,256
|
28,646
|
28,706
|
34,545
|
Total assets |
40,834
|
45,908
|
56,669
|
56,232
|
58,381
|
69,052
|
Solvency |
52.28
|
46.92
|
44.84
|
49.06
|
50.83
|
49.97
|
Cash |
466
|
802
|
1,345
|
2,134
|
2,436
|
10,353
|
Cashflow |
2,817
|
3,258
|
4,005
|
4,543
|
4,973
|
8,289
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.14
|
0.13
|
0.13
|
0.16
|
0.17
|
0.24
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
141.85
|
141.10
|
189.88
|
223.79
|
324.87
|
Eps |
5.09
|
5.59
|
7.24
|
9.17
|
15.98
|
Price/earnings-ratio |
27.87
|
25.24
|
26.23
|
24.40
|
33.84
|
Dividend |
0.60
|
0.60
|
0.66
|
0.74
|
0.85
|
Dividend % |
0.42 %
|
0.43 %
|
0.35 %
|
0.33 %
|
0.16 %
|
Payout % |
0.12
|
0.11
|
0.09
|
0.08
|
0.05
|
Book value |
54.74
|
63.32
|
68.60
|
74.42
|
86.99
|
Market to book |
0.39
|
0.45
|
0.36
|
0.33
|
0.16
|
Cashflow per stock |
8.28
|
9.98
|
11.30
|
12.47
|
20.90
|
Stocks |
393
|
401
|
402
|
399
|
397
|
Market Cap |
55.810.58
|
56.625.48
|
76.354.93
|
89.234.02
|
214.499.30
|
Date
|
Price
|
---|---|
13 Nov 2024
|
540.75
|
08 Nov 2024
|
555.89
|
05 Nov 2024
|
555.47
|
31 Oct 2024
|
550.62
|
29 Oct 2024
|
552.54
|
23 Oct 2024
|
586.38
|
19 Oct 2024
|
601.71
|
16 Oct 2024
|
600.52
|
14 Oct 2024
|
596.92
|
05 Oct 2024
|
598.61
|
02 Oct 2024
|
612.94
|
27 Sep 2024
|
619.33
|
20 Sep 2024
|
620.25
|
17 Sep 2024
|
614.15
|
13 Sep 2024
|
614.16
|
28 Aug 2024
|
610.40
|
26 Aug 2024
|
606.12
|
23 Aug 2024
|
603.86
|
11 Aug 2024
|
596.18
|
07 Aug 2024
|
587.37
|
05 Aug 2024
|
615.69
|
01 Aug 2024
|
613.34
|
30 Jul 2024
|
604.12
|
26 Jul 2024
|
594.50
|
23 Jul 2024
|
546.42
|
16 Jul 2024
|
544.68
|
10 Jul 2024
|
536.87
|
09 Jul 2024
|
536.29
|
04 Jul 2024
|
535.61
|
02 Jul 2024
|
556.52
|